Funding for this research was provided by:
American Cancer Society (MRSG-14-014-01-CCE)
Received: 22 July 2020
Accepted: 2 February 2021
First Online: 9 February 2021
Ethics approval and consent to participate
: This study used de-identified data from the Surveillance, Epidemiology and End Results (SEER)-Medicare database and did not require informed consent to be obtained from this database. The Institutional Review Board of the Mount Sinai School of Medicine approved this study.
: Not applicable.
: Dr. Michelle Kim has consulted for Ipsen and Novartis.